

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.82676354 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.82676354 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.53451509 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.24222891 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.76372578 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.60721685 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.54389190 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.54389190 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.54389190 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.54389190 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.54389190 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 4.54389190 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.49004529 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.38626257 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.21763014 |
| 16 | response to muramyl dipeptide (GO:0032495) | 4.19908756 |
| 17 | response to peptidoglycan (GO:0032494) | 4.08846403 |
| 18 | detection of bacterium (GO:0016045) | 4.05599024 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.04098216 |
| 20 | leukocyte aggregation (GO:0070486) | 4.03248798 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 4.02408765 |
| 22 | detection of other organism (GO:0098543) | 4.00048295 |
| 23 | NIK/NF-kappaB signaling (GO:0038061) | 3.96797251 |
| 24 | mannose metabolic process (GO:0006013) | 3.95437376 |
| 25 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.93959146 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.91853311 |
| 27 | germinal center formation (GO:0002467) | 3.89305578 |
| 28 | positive thymic T cell selection (GO:0045059) | 3.87086679 |
| 29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.83049377 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 3.78418219 |
| 31 | thymic T cell selection (GO:0045061) | 3.74690820 |
| 32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.71059947 |
| 33 | negative thymic T cell selection (GO:0045060) | 3.65825877 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 3.60533860 |
| 35 | response to type I interferon (GO:0034340) | 3.59462533 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.55595789 |
| 37 | type I interferon signaling pathway (GO:0060337) | 3.55472312 |
| 38 | cellular response to type I interferon (GO:0071357) | 3.55472312 |
| 39 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.39912118 |
| 40 | negative T cell selection (GO:0043383) | 3.39887938 |
| 41 | B cell receptor signaling pathway (GO:0050853) | 3.38480719 |
| 42 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.36860988 |
| 43 | negative regulation of interleukin-12 production (GO:0032695) | 3.34648586 |
| 44 | tolerance induction (GO:0002507) | 3.34494999 |
| 45 | T cell selection (GO:0045058) | 3.33925982 |
| 46 | defense response to protozoan (GO:0042832) | 3.27743842 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.27366081 |
| 48 | negative regulation of innate immune response (GO:0045824) | 3.23782657 |
| 49 | response to interleukin-15 (GO:0070672) | 3.21313084 |
| 50 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.17594588 |
| 51 | detection of external biotic stimulus (GO:0098581) | 3.16683629 |
| 52 | response to host immune response (GO:0052572) | 3.12870835 |
| 53 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.12870835 |
| 54 | regulation of T cell tolerance induction (GO:0002664) | 3.12576899 |
| 55 | cellular extravasation (GO:0045123) | 3.10244373 |
| 56 | negative regulation of T cell mediated immunity (GO:0002710) | 3.06922541 |
| 57 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.06627369 |
| 58 | response to protozoan (GO:0001562) | 3.06075526 |
| 59 | regulation of mast cell degranulation (GO:0043304) | 3.05579283 |
| 60 | regulation of B cell differentiation (GO:0045577) | 3.04145853 |
| 61 | positive T cell selection (GO:0043368) | 3.02847488 |
| 62 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.00387762 |
| 63 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97499915 |
| 64 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.92844143 |
| 65 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.92266609 |
| 66 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.92266609 |
| 67 | neutrophil activation (GO:0042119) | 2.91729345 |
| 68 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.91098519 |
| 69 | myeloid cell activation involved in immune response (GO:0002275) | 2.90096932 |
| 70 | regulation of tolerance induction (GO:0002643) | 2.89668470 |
| 71 | regulation of necroptotic process (GO:0060544) | 2.88804881 |
| 72 | T cell migration (GO:0072678) | 2.88654394 |
| 73 | response to host (GO:0075136) | 2.87715181 |
| 74 | response to host defenses (GO:0052200) | 2.87715181 |
| 75 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.87715181 |
| 76 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.87667661 |
| 77 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87204359 |
| 78 | positive regulation of interferon-alpha production (GO:0032727) | 2.86382773 |
| 79 | detection of biotic stimulus (GO:0009595) | 2.85081349 |
| 80 | regulation of leukocyte degranulation (GO:0043300) | 2.84845573 |
| 81 | respiratory burst (GO:0045730) | 2.83319911 |
| 82 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.82627351 |
| 83 | positive regulation of B cell differentiation (GO:0045579) | 2.82280592 |
| 84 | macrophage activation (GO:0042116) | 2.82139303 |
| 85 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.81638294 |
| 86 | B cell homeostasis (GO:0001782) | 2.81098990 |
| 87 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.80901238 |
| 88 | regulation of antigen processing and presentation (GO:0002577) | 2.78842765 |
| 89 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.74793953 |
| 90 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.74793953 |
| 91 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.72716946 |
| 92 | B cell mediated immunity (GO:0019724) | 2.72466019 |
| 93 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.70036418 |
| 94 | granulocyte activation (GO:0036230) | 2.69806405 |
| 95 | regulation of interferon-alpha production (GO:0032647) | 2.68791297 |
| 96 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.68203981 |
| 97 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.67897109 |
| 98 | positive regulation of antigen processing and presentation (GO:0002579) | 2.67477044 |
| 99 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.67210875 |
| 100 | negative regulation of type 2 immune response (GO:0002829) | 2.67078197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.94412952 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.45516192 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.09586183 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.97998578 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.84888589 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.78747722 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.77965219 |
| 8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.63492573 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57463224 |
| 10 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.50574586 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.49519915 |
| 12 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.49133350 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.48009333 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.37341987 |
| 15 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.33557408 |
| 16 | MAF_26560356_Chip-Seq_TH2_Human | 2.18398492 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14744513 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.14211329 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13858116 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.11995468 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08077831 |
| 22 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.06300045 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06188112 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.99887314 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.99486086 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98990697 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98843836 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.92023810 |
| 29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.86287448 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84254647 |
| 31 | P68_20966046_ChIP-Seq_HELA_Human | 1.77376758 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76427451 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76298764 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74872435 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74214535 |
| 36 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.71807631 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71025001 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69648686 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68768624 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.67261843 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67019131 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.66966223 |
| 43 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.63592317 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.61634170 |
| 45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.60637849 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.59611127 |
| 47 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.59432076 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.59042957 |
| 49 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.58676770 |
| 50 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.58446651 |
| 51 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.58086192 |
| 52 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.56849231 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.56630079 |
| 54 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50559898 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.44141351 |
| 56 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43051961 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43038444 |
| 58 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.42762359 |
| 59 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.41907814 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41387862 |
| 61 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.41072552 |
| 62 | KDM2B_26808549_Chip-Seq_K562_Human | 1.38744391 |
| 63 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.36111134 |
| 64 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.29722107 |
| 65 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.27891374 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.26813312 |
| 67 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.23688300 |
| 68 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.23521414 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23420313 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23267990 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21788228 |
| 72 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.21207937 |
| 73 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.19774162 |
| 74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19507236 |
| 75 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.19088504 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18421653 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17533862 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17508747 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16157659 |
| 80 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15918370 |
| 81 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.14319592 |
| 82 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.13783079 |
| 83 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.12806021 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11868040 |
| 85 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11420284 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11219444 |
| 87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11043292 |
| 88 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09236667 |
| 89 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08453106 |
| 90 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06578241 |
| 91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.05773261 |
| 92 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05390510 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05117200 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04734888 |
| 95 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04512650 |
| 96 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03983877 |
| 97 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02772723 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02694830 |
| 99 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02647962 |
| 100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00926910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.03627298 |
| 2 | MP0003724_increased_susceptibility_to | 3.46403161 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.38867961 |
| 4 | MP0003303_peritoneal_inflammation | 3.29041646 |
| 5 | MP0001800_abnormal_humoral_immune | 2.92111545 |
| 6 | MP0001790_abnormal_immune_system | 2.91661590 |
| 7 | MP0005387_immune_system_phenotype | 2.91661590 |
| 8 | MP0005671_abnormal_response_to | 2.68965294 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.68022026 |
| 10 | MP0005451_abnormal_body_composition | 2.65994873 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.64000522 |
| 12 | MP0000685_abnormal_immune_system | 2.61124716 |
| 13 | MP0005025_abnormal_response_to | 2.57458123 |
| 14 | MP0002419_abnormal_innate_immunity | 2.50401675 |
| 15 | MP0002723_abnormal_immune_serum | 2.47518403 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.39441385 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.34526507 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.30443618 |
| 19 | MP0004510_myositis | 2.29949258 |
| 20 | MP0001819_abnormal_immune_cell | 2.29156564 |
| 21 | MP0002396_abnormal_hematopoietic_system | 2.18199841 |
| 22 | MP0009785_altered_susceptibility_to | 2.15373497 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.13874711 |
| 24 | MP0009278_abnormal_bone_marrow | 2.07166150 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.90928613 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.87048301 |
| 27 | MP0002398_abnormal_bone_marrow | 1.86628608 |
| 28 | MP0000716_abnormal_immune_system | 1.83279207 |
| 29 | MP0001873_stomach_inflammation | 1.81789756 |
| 30 | MP0004381_abnormal_hair_follicle | 1.73685366 |
| 31 | MP0002405_respiratory_system_inflammati | 1.73601661 |
| 32 | MP0004947_skin_inflammation | 1.73243668 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.71526024 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.69513832 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.62142064 |
| 36 | MP0008260_abnormal_autophagy | 1.58647364 |
| 37 | MP0003646_muscle_fatigue | 1.52159569 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.49292421 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.48793303 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.47631767 |
| 41 | MP0002429_abnormal_blood_cell | 1.44863092 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.44540981 |
| 43 | MP0002722_abnormal_immune_system | 1.43812089 |
| 44 | MP0006082_CNS_inflammation | 1.43425688 |
| 45 | MP0000749_muscle_degeneration | 1.40897182 |
| 46 | MP0002132_abnormal_respiratory_system | 1.39028619 |
| 47 | MP0003866_abnormal_defecation | 1.37391743 |
| 48 | MP0002933_joint_inflammation | 1.37298919 |
| 49 | MP0005310_abnormal_salivary_gland | 1.27547973 |
| 50 | MP0008469_abnormal_protein_level | 1.26272453 |
| 51 | MP0003828_pulmonary_edema | 1.24914413 |
| 52 | MP0000751_myopathy | 1.24754927 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.19584011 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.18233107 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.17652457 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.17652457 |
| 57 | MP0005666_abnormal_adipose_tissue | 1.14014841 |
| 58 | MP0004036_abnormal_muscle_relaxation | 1.11985885 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.07516946 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.01059784 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.00272531 |
| 62 | MP0005375_adipose_tissue_phenotype | 1.00126675 |
| 63 | MP0005076_abnormal_cell_differentiation | 0.98757734 |
| 64 | MP0001986_abnormal_taste_sensitivity | 0.98304299 |
| 65 | MP0004130_abnormal_muscle_cell | 0.94834943 |
| 66 | MP0009764_decreased_sensitivity_to | 0.94821968 |
| 67 | MP0000858_altered_metastatic_potential | 0.92652161 |
| 68 | MP0004084_abnormal_cardiac_muscle | 0.91353973 |
| 69 | MP0004087_abnormal_muscle_fiber | 0.91227056 |
| 70 | MP0001851_eye_inflammation | 0.89135726 |
| 71 | MP0002106_abnormal_muscle_physiology | 0.88800777 |
| 72 | MP0000013_abnormal_adipose_tissue | 0.87187657 |
| 73 | MP0002166_altered_tumor_susceptibility | 0.87164557 |
| 74 | MP0009840_abnormal_foam_cell | 0.86757335 |
| 75 | MP0010630_abnormal_cardiac_muscle | 0.85271050 |
| 76 | MP0000747_muscle_weakness | 0.84137953 |
| 77 | MP0003183_abnormal_peptide_metabolism | 0.83789384 |
| 78 | MP0005330_cardiomyopathy | 0.83749157 |
| 79 | MP0001849_ear_inflammation | 0.83411294 |
| 80 | MP0001663_abnormal_digestive_system | 0.81640589 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.81293280 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.81265074 |
| 83 | MP0000465_gastrointestinal_hemorrhage | 0.80932626 |
| 84 | MP0008874_decreased_physiological_sensi | 0.78855272 |
| 85 | MP0000003_abnormal_adipose_tissue | 0.76851573 |
| 86 | MP0004484_altered_response_of | 0.76167332 |
| 87 | MP0001853_heart_inflammation | 0.75898261 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.74633504 |
| 89 | MP0000678_abnormal_parathyroid_gland | 0.73131435 |
| 90 | MP0000759_abnormal_skeletal_muscle | 0.72339353 |
| 91 | MP0006138_congestive_heart_failure | 0.71621240 |
| 92 | MP0000750_abnormal_muscle_regeneration | 0.70089771 |
| 93 | MP0003075_altered_response_to | 0.68757675 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.66870134 |
| 95 | MP0003045_fibrosis | 0.66181006 |
| 96 | MP0004145_abnormal_muscle_electrophysio | 0.65083051 |
| 97 | MP0005166_decreased_susceptibility_to | 0.63249883 |
| 98 | MP0008004_abnormal_stomach_pH | 0.63130822 |
| 99 | MP0005390_skeleton_phenotype | 0.62811351 |
| 100 | MP0003795_abnormal_bone_structure | 0.61597237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.15978539 |
| 2 | Myositis (HP:0100614) | 4.12243108 |
| 3 | Abnormality of macrophages (HP:0004311) | 3.95085860 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.93890523 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.93581463 |
| 6 | Increased IgE level (HP:0003212) | 3.77363443 |
| 7 | Colitis (HP:0002583) | 3.71385223 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.68762564 |
| 9 | Meningitis (HP:0001287) | 3.52363802 |
| 10 | Recurrent fungal infections (HP:0002841) | 3.44336886 |
| 11 | Orchitis (HP:0100796) | 3.42851833 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.39981328 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 3.36520442 |
| 14 | Gastrointestinal inflammation (HP:0004386) | 3.35597917 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 3.34458412 |
| 16 | Inflammation of the large intestine (HP:0002037) | 3.33366321 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.29054092 |
| 18 | Optic neuritis (HP:0100653) | 3.29054092 |
| 19 | Exercise-induced myalgia (HP:0003738) | 3.25958147 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.18823833 |
| 21 | Obstructive lung disease (HP:0006536) | 3.18823833 |
| 22 | Asymmetric septal hypertrophy (HP:0001670) | 3.16174487 |
| 23 | Stomatitis (HP:0010280) | 3.15566244 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.13361705 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.11503287 |
| 26 | Vasculitis (HP:0002633) | 3.08820590 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.01094838 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.01094838 |
| 29 | Pustule (HP:0200039) | 3.00472260 |
| 30 | Muscle fiber splitting (HP:0003555) | 3.00379151 |
| 31 | Gastrointestinal stroma tumor (HP:0100723) | 2.99198951 |
| 32 | Chest pain (HP:0100749) | 2.89153401 |
| 33 | Encephalitis (HP:0002383) | 2.88173805 |
| 34 | Spontaneous hematomas (HP:0007420) | 2.87690065 |
| 35 | Obstructive sleep apnea (HP:0002870) | 2.83587150 |
| 36 | Recurrent skin infections (HP:0001581) | 2.80819742 |
| 37 | Recurrent viral infections (HP:0004429) | 2.77597572 |
| 38 | Difficulty running (HP:0009046) | 2.71860695 |
| 39 | Myopathic facies (HP:0002058) | 2.69576906 |
| 40 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.67703076 |
| 41 | Prolonged bleeding time (HP:0003010) | 2.67513376 |
| 42 | Agammaglobulinemia (HP:0004432) | 2.65735024 |
| 43 | Gingivitis (HP:0000230) | 2.65212833 |
| 44 | Subaortic stenosis (HP:0001682) | 2.65112509 |
| 45 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.65112509 |
| 46 | Cellulitis (HP:0100658) | 2.57116494 |
| 47 | Muscle fiber inclusion bodies (HP:0100299) | 2.52621323 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.45314920 |
| 49 | Ragged-red muscle fibers (HP:0003200) | 2.43157160 |
| 50 | Nemaline bodies (HP:0003798) | 2.42818716 |
| 51 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.40811639 |
| 52 | Restrictive lung disease (HP:0002091) | 2.40801390 |
| 53 | Hemoptysis (HP:0002105) | 2.35354601 |
| 54 | EMG: myopathic abnormalities (HP:0003458) | 2.34165678 |
| 55 | Increased connective tissue (HP:0009025) | 2.32407815 |
| 56 | EMG: neuropathic changes (HP:0003445) | 2.32217094 |
| 57 | J-shaped sella turcica (HP:0002680) | 2.31946348 |
| 58 | Abnormality of the endocardium (HP:0004306) | 2.29709154 |
| 59 | Lymphopenia (HP:0001888) | 2.27643644 |
| 60 | Hypochromic anemia (HP:0001931) | 2.26959423 |
| 61 | Broad face (HP:0000283) | 2.25181387 |
| 62 | Emphysema (HP:0002097) | 2.23276587 |
| 63 | Metaphyseal cupping (HP:0003021) | 2.22143381 |
| 64 | Distal lower limb muscle weakness (HP:0009053) | 2.21673785 |
| 65 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.20272727 |
| 66 | Urticaria (HP:0001025) | 2.18955639 |
| 67 | Easy fatigability (HP:0003388) | 2.18367448 |
| 68 | Dysostosis multiplex (HP:0000943) | 2.16668589 |
| 69 | Increased IgM level (HP:0003496) | 2.15548645 |
| 70 | Keratoconjunctivitis sicca (HP:0001097) | 2.14615848 |
| 71 | Epistaxis (HP:0000421) | 2.14354524 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.14008575 |
| 73 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.12462364 |
| 74 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.11698166 |
| 75 | Malnutrition (HP:0004395) | 2.11476331 |
| 76 | Type 1 muscle fiber predominance (HP:0003803) | 2.11381359 |
| 77 | Abnormality of the fingertips (HP:0001211) | 2.11366072 |
| 78 | Ulnar deviation of the wrist (HP:0003049) | 2.10619767 |
| 79 | Granulocytopenia (HP:0001913) | 2.09550609 |
| 80 | Bulbar palsy (HP:0001283) | 2.08112586 |
| 81 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.07829503 |
| 82 | Abnormality of T cells (HP:0002843) | 2.06618979 |
| 83 | Osteomyelitis (HP:0002754) | 2.06030457 |
| 84 | Arterial thrombosis (HP:0004420) | 2.02920340 |
| 85 | Hyporeflexia of lower limbs (HP:0002600) | 2.01472705 |
| 86 | Increased serum ferritin (HP:0003281) | 2.01151776 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 1.99173036 |
| 88 | Thin bony cortex (HP:0002753) | 1.98313225 |
| 89 | Fatigue (HP:0012378) | 1.98014186 |
| 90 | Increased variability in muscle fiber diameter (HP:0003557) | 1.97542281 |
| 91 | Bundle branch block (HP:0011710) | 1.96117367 |
| 92 | Ventricular tachycardia (HP:0004756) | 1.96066887 |
| 93 | Papilloma (HP:0012740) | 1.95998342 |
| 94 | Verrucae (HP:0200043) | 1.95998342 |
| 95 | Calf muscle hypertrophy (HP:0008981) | 1.94346996 |
| 96 | Rhabdomyolysis (HP:0003201) | 1.92397699 |
| 97 | Thoracic kyphosis (HP:0002942) | 1.90812361 |
| 98 | Keratoconjunctivitis (HP:0001096) | 1.90066111 |
| 99 | Episodic fever (HP:0001954) | 1.87504672 |
| 100 | Gingival bleeding (HP:0000225) | 1.86451187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.04492230 |
| 2 | TRIB3 | 3.24445814 |
| 3 | RIPK4 | 3.06699295 |
| 4 | ERN1 | 2.68404436 |
| 5 | MAP2K3 | 2.55501708 |
| 6 | PRPF4B | 2.44945729 |
| 7 | TNK2 | 2.44614922 |
| 8 | MAPK15 | 2.34248703 |
| 9 | BLK | 2.27407490 |
| 10 | TYK2 | 2.19088037 |
| 11 | IRAK4 | 2.13978760 |
| 12 | SIK2 | 1.99032673 |
| 13 | SIK1 | 1.92794167 |
| 14 | ZAP70 | 1.91567331 |
| 15 | TBK1 | 1.90482284 |
| 16 | MAP3K14 | 1.90030810 |
| 17 | IKBKE | 1.90017975 |
| 18 | TTN | 1.87634959 |
| 19 | SIK3 | 1.72950662 |
| 20 | CSK | 1.72303298 |
| 21 | FGFR4 | 1.67121036 |
| 22 | JAK3 | 1.66559021 |
| 23 | FES | 1.65859269 |
| 24 | MAP3K13 | 1.63859874 |
| 25 | MAP2K6 | 1.59423452 |
| 26 | MARK2 | 1.53483477 |
| 27 | TAOK1 | 1.51605940 |
| 28 | MAP3K7 | 1.49301182 |
| 29 | GRK6 | 1.42438098 |
| 30 | BTK | 1.40528296 |
| 31 | MAP3K6 | 1.37443743 |
| 32 | MAP3K10 | 1.35272697 |
| 33 | CSF1R | 1.33328165 |
| 34 | TXK | 1.29305238 |
| 35 | PRKD2 | 1.29282753 |
| 36 | EPHB1 | 1.27533386 |
| 37 | MAP3K11 | 1.24277311 |
| 38 | CDC42BPA | 1.24230501 |
| 39 | SYK | 1.21138044 |
| 40 | ITK | 1.19455669 |
| 41 | HCK | 1.17808203 |
| 42 | MAPK12 | 1.13575634 |
| 43 | OBSCN | 1.12126891 |
| 44 | TAOK2 | 1.09779899 |
| 45 | IKBKB | 1.05814371 |
| 46 | FGR | 1.05581438 |
| 47 | SMG1 | 1.04822586 |
| 48 | KIT | 1.02038189 |
| 49 | JAK1 | 0.97648394 |
| 50 | MAP3K1 | 0.92848092 |
| 51 | MAP2K2 | 0.92020916 |
| 52 | LYN | 0.91830728 |
| 53 | LCK | 0.91532863 |
| 54 | CDK12 | 0.89746179 |
| 55 | FGFR3 | 0.89341889 |
| 56 | MARK3 | 0.88849598 |
| 57 | MAPK7 | 0.88366684 |
| 58 | MATK | 0.86899155 |
| 59 | RPS6KC1 | 0.83659749 |
| 60 | RPS6KL1 | 0.83659749 |
| 61 | PKN2 | 0.82199622 |
| 62 | MAP3K3 | 0.80898016 |
| 63 | PTK6 | 0.79240916 |
| 64 | PDPK1 | 0.74026172 |
| 65 | PDK1 | 0.72273554 |
| 66 | HIPK2 | 0.69355126 |
| 67 | DYRK1B | 0.69116506 |
| 68 | RPS6KA6 | 0.68583494 |
| 69 | JAK2 | 0.66203925 |
| 70 | EEF2K | 0.64179268 |
| 71 | CHUK | 0.62165401 |
| 72 | TAOK3 | 0.57639461 |
| 73 | RPS6KA2 | 0.57500013 |
| 74 | IRAK1 | 0.56935743 |
| 75 | MAPK11 | 0.54570068 |
| 76 | PIK3CG | 0.53895616 |
| 77 | RIPK1 | 0.53440386 |
| 78 | CDK4 | 0.52368329 |
| 79 | RET | 0.48899288 |
| 80 | MAP2K4 | 0.48142582 |
| 81 | BMX | 0.47964811 |
| 82 | PRKD1 | 0.46891681 |
| 83 | CAMKK1 | 0.46625559 |
| 84 | IRAK3 | 0.46409467 |
| 85 | KSR2 | 0.44732347 |
| 86 | ICK | 0.44259898 |
| 87 | PRKCQ | 0.43908132 |
| 88 | TYRO3 | 0.43687913 |
| 89 | TEC | 0.43675804 |
| 90 | RPS6KA1 | 0.42900221 |
| 91 | MAPK4 | 0.41348833 |
| 92 | PASK | 0.38554043 |
| 93 | PTK2B | 0.35353451 |
| 94 | PRKCH | 0.35018881 |
| 95 | NME1 | 0.34950244 |
| 96 | IRAK2 | 0.34078331 |
| 97 | PHKG1 | 0.33993287 |
| 98 | PHKG2 | 0.33993287 |
| 99 | MTOR | 0.33161134 |
| 100 | MAPK3 | 0.33115576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.61322150 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.59071127 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.50108657 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.48971581 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.45139429 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.42005560 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.32091620 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.25714125 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.10159969 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.93428676 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.91393289 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.90256967 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85311505 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.84492422 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.81442733 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.81207626 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78153963 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75679563 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72421313 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.72310353 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.71285296 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.67195496 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.66742526 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.64726900 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60697986 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.55691099 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.54634115 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48393909 |
| 29 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.48024592 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47211319 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.42899751 |
| 32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.39926832 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28156397 |
| 34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.22166368 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.18546876 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12685455 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10330933 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.09612625 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07427298 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.07180390 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06454160 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05880536 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04178689 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02166128 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01882158 |
| 46 | Malaria_Homo sapiens_hsa05144 | 0.99436196 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98828719 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.98493395 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 0.96219616 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95620592 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94080929 |
| 52 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.93878070 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85537475 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84607557 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.84374380 |
| 56 | Pertussis_Homo sapiens_hsa05133 | 0.84370448 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81802566 |
| 58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.80256795 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.79003389 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78368365 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78298018 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77971638 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77654753 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76379170 |
| 65 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75877391 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72590805 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72494097 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67830418 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67572174 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67225619 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66099878 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65650375 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65636725 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.65636243 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64603783 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.63902337 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63281397 |
| 78 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62925012 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61124523 |
| 80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60065175 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.58119817 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57770383 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56566736 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56400990 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.55052861 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54252369 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52921741 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50936294 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.50384588 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48081717 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46271343 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44914760 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42737311 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | 0.42715972 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42337502 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38605419 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37765778 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37693786 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36852110 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36446112 |

